Skip to main content
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
EN
FR
EN
PT
NL
NB
DE
IT
Home
Company Press Releases
Company press releases
Subscribe
Filters
Filters
Refresh
Reset
Icon After
Date
Toggle Visibility
All
Today
This week
This month
Custom date range
From
To
Topic
Toggle Visibility
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 51 - 89 of 89 results
Released
Company
Title
Industry
Topic
22 Feb 2023
18:00 CET
AELIS FARMA
CORRIGE ET REMPLACE : Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities
20103010 Biotechnology
Other subject
21 Feb 2023
18:35 CET
AELIS FARMA
Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities
20103010 Biotechnology
Other subject
31 Jan 2023
17:45 CET
AELIS FARMA
Aelis Farma Announces its 2023 Financial Calendar
20103010 Biotechnology
Legal
31 Jan 2023
17:45 CET
AELIS FARMA
Aelis Farma annonce son calendrier financier pour l’exercice 2023
20103010 Biotechnology
Legal
12 Jan 2023
18:00 CET
AELIS FARMA
Aelis Farma : Bilan semestriel du contrat de liquidité
20103010 Biotechnology
Legal
27 Dec 2022
07:00 CET
AELIS FARMA
Aelis Farma : Résiliation du contrat de liquidité avec Oddo BHF SCA
20103010 Biotechnology
Other subject
16 Dec 2022
07:00 CET
AELIS FARMA
Aelis Farma annonce le recrutement du premier patient de l’étude clinique de phase 1/2 avec son candidat-médicament AEF0217 pour le traitement des troubles cognitifs de la trisomie 21
20103010 Biotechnology
Other subject
16 Dec 2022
07:00 CET
AELIS FARMA
Aelis Farma Announces the Recruitment of the First Patient for the Phase 1/2 Clinical Trial of Its Drug Candidate AEF0217 for the Treatment of Cognitive Disorders in Down Syndrome
20103010 Biotechnology
Other subject
15 Nov 2022
18:00 CET
AELIS FARMA
Aelis Farma annonce les résultats positifs d’études de sécurité chez des volontaires sains et l’autorisation d’initier la première étude chez des personnes trisomiques avec son candidat-médicament AEF0217 visant le traitement des troubles cognitifs
20103010 Biotechnology
New
15 Nov 2022
18:00 CET
AELIS FARMA
Aelis Farma Announces Positive Results From Its Safety Trials in Healthy Volunteers and the Authorization to Start the First Trial in People with Down Syndrome with AEF0217, its Drug Candidate for the Treatment of Cognitive Disorders
20103010 Biotechnology
New
04 Oct 2022
07:00 CEST
AELIS FARMA
Le Directeur Général d’Aelis Farma, Pier Vincenzo Piazza, reçoit le Prix de l’Entrepreneur de l’Année décerné par EY
20103010 Biotechnology
Other subject
04 Oct 2022
07:00 CEST
AELIS FARMA
Aelis Farma CEO Pier Vincenzo Piazza Receives the EY Entrepreneur of the Year Award
20103010 Biotechnology
Other subject
27 Sep 2022
18:00 CEST
AELIS FARMA
Aelis Farma: Availability of the 2022 Half-year Financial Report
20103010 Biotechnology
Other subject
27 Sep 2022
18:00 CEST
AELIS FARMA
Aelis Farma : Mise à disposition du rapport financier semestriel 2022
20103010 Biotechnology
Other subject
26 Sep 2022
07:00 CEST
AELIS FARMA
Aelis Farma reports 2022 half-year financial results and confirms its development objectives
20103010 Biotechnology
Income
26 Sep 2022
07:00 CEST
AELIS FARMA
Aelis Farma publie ses résultats financiers semestriels 2022 et confirme ses perspectives de développement
20103010 Biotechnology
Income
22 Sep 2022
18:13 CEST
AELIS FARMA
Aelis Farma Will Participate in the Addiction 2022 Conference Dedicated to Innovation in the Treatment of Addictions
20103010 Biotechnology
New
22 Sep 2022
18:13 CEST
AELIS FARMA
Aelis Farma participera à la conférence Addiction 2022 dédiée à l’innovation dans le traitement des addictions
20103010 Biotechnology
New
06 Jul 2022
18:00 CEST
AELIS FARMA
Aelis Farma : Bilan semestriel du contrat de liquidité contracté avec Natixis ODDO BHF
20103010 Biotechnology
Other subject
07 Jun 2022
18:00 CEST
AELIS FARMA
Aelis Farma: Ordinary General Meeting of June 28, 2022: Availability of Preparatory Documents and Participation and Voting Procedures
20103010 Biotechnology
Other subject
07 Jun 2022
18:00 CEST
AELIS FARMA
Aelis Farma : Assemblée générale ordinaire du 28 juin 2022 : mise à disposition des documents préparatoires et modalités de participation et de vote
20103010 Biotechnology
Other subject
01 Jun 2022
09:25 CEST
AELIS FARMA
Aelis Farma Announces the Inclusion of the 1st Patient in a Phase 2b Study of AEF0117 for the Treatment of Cannabis Use Disorder (CUD)
20103010 Biotechnology
New
01 Jun 2022
09:25 CEST
AELIS FARMA
Aelis Farma annonce l’inclusion du 1er patient d’une étude de phase 2b avec AEF0117 dans le traitement de l’addiction au cannabis
20103010 Biotechnology
New
26 Apr 2022
18:00 CEST
AELIS FARMA
Aelis Farma: Publication of the 2021 Annual Financial Report
20103010 Biotechnology
Other subject
26 Apr 2022
18:00 CEST
AELIS FARMA
Aelis Farma : Mise à disposition du rapport financier annuel 2021
20103010 Biotechnology
Other subject
25 Apr 2022
18:18 CEST
AELIS FARMA
Aelis Farma : Information relative au nombre total de droits de vote et d’actions composant le capital social
20103010 Biotechnology
Other subject
11 Apr 2022
18:13 CEST
AELIS FARMA
ODDO BHF initie à l’achat la couverture d’Aelis Farma
20103010 Biotechnology
Other subject
11 Apr 2022
18:13 CEST
AELIS FARMA
ODDO BHF Initiates the Coverage of Aelis Farma With a “Buy” Recommendation
20103010 Biotechnology
Other subject
04 Apr 2022
07:00 CEST
AELIS FARMA
Aelis Farma Reports 2021 Annual Financial Results and Confirms Its 2022 Outlook
20103010 Biotechnology
Other subject
04 Apr 2022
07:00 CEST
AELIS FARMA
Aelis Farma publie ses résultats financiers annuels 2021 et confirme ses perspectives 2022
20103010 Biotechnology
Other subject
30 Mar 2022
17:45 CEST
AELIS FARMA
Bryan Garnier & Co Initiates the Coverage of Aelis Farma With a “Buy” Recommendation
20103010 Biotechnology
Other subject
30 Mar 2022
17:45 CEST
AELIS FARMA
Bryan Garnier & Co initie à l’achat la couverture d’Aelis Farma
20103010 Biotechnology
Other subject
18 Mar 2022
07:00 CET
AELIS FARMA
Aelis Farma : mise en œuvre d’un contrat de liquidité avec ODDO BHF SCA et descriptif du programme de rachat
20103010 Biotechnology
Other subject
17 Mar 2022
21:23 CET
AELIS FARMA
Aelis Farma annonce la fin de la période de stabilisation et l’exercice partiel de l’option de surallocation
20103010 Biotechnology
Other subject
10 Mar 2022
19:29 CET
AELIS FARMA
Aelis Farma : Opérations de stabilisation
20103010 Biotechnology
Other subject
03 Mar 2022
19:00 CET
AELIS FARMA
Aelis Farma : Opérations de stabilisation
20103010 Biotechnology
Other subject
24 Feb 2022
19:23 CET
AELIS FARMA
Aelis Farma : Opérations de stabilisation
20103010 Biotechnology
Other subject
16 Feb 2022
00:07 CET
AELIS FARMA
Aelis Farma, a biopharmaceutical company developing a new generation of drugs for brain diseases, announces the success of its initial public offering and raises approximately €25 million on Euronext Paris
20103010 Biotechnology
Other subject
16 Feb 2022
00:07 CET
AELIS FARMA
Aelis Farma, société biopharmaceutique à l’origine d’une nouvelle génération de médicaments pour les maladies du cerveau, annonce le succès de son introduction en bourse et lève environ 25 millions d’euros sur Euronext Paris
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Pagination
«
« First
‹
‹‹
1
2
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Markets
Amsterdam
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Brussels
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisbon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Equities
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Funds
Directory
ESG Funds
Oslo Mutual Funds
Fixed Income
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Structured Products
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Equity Derivatives
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Commodities
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Resources
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Where to find